Citations

Clear

371 citation(s) found for "Cho, B".

Mechanism of MDSC induced T cell tolerance in cancer (88.26)
Nagaraj, Srinivas, Cho, Hyun-II, Schrum, Adam G. , Celis, Esteban , Gabrilovich, Dmitry I.

Mayo Clinic

The Journal of Immunology | December 31, 2022 | Volume: 182 | Issue: Supplement_1 | Pages: 88.26-88.26

10.4049/jimmunol.182.supp.88.26 Get It

Abstract Tumor antigen-specific T-cell tolerance is a critical element of tumor escape. It is known that MDSC can induce antigen-specific CD8+ T cell tolerance in an experimental system with adoptive transfer of transgenic T cells. In this study we addressed the critical question whether a similar phenomenon can be observed in a "natural" non-transgenic experimental model. Balb/C mice were subcutaneously inoculated with two different tumor cell lines, a derivative A2L2 cell line, which expresses high levels of HER2/neu and the parental cell line 66.3. HER2/neu specific CD8+T cells were generated by immunization of mice with peptide. MDSC were able to tolerize antigen-specific T cells in vivo if they were collected from A2L2 but not from 66.3 tumor-bearing mice indicating the tumor-specific nature of T cell tolerance induced by MDSC. Next we investigated the type of signaling caused by MDSC in CD8+T cells that could lead to tolerance. MDSC dramatically reduced the ability of CD8+ T cells to respond to the specific peptide. However, study of various signaling molecules using different experimental systems and tests found that MDSC did not induce negative signaling in T cells. This conclusion was confirmed in adoptive transfer experiments with CD8+T cells expressing dual TCR: LCMV glycoprotein peptide gp33-41 and OVA-derived H-2Kb-restricted peptide ova257-264. We found that MDSC loaded with peptide specific for one TCR induced tolerance only against that specific epitope but CD8+ T cells retained the ability to respond to the peptide specific for the other TCR expressed on the same cell.
Paging the Clinical Informatics Community: Respond STAT to Dobbs v. Jackson's Women's Health Organization
Ravi, Akshay , Weia, Benjamin , Aarts, Jos , Ahmad, Hasan B., Araj, Ellen, Bauml, Julie A., Boyd, Andrew D. , Brecht-Doscher, Aimee, Butler‐Henderson, Kerryn , Butte, Atul J. , Cardilo, Anthony B., Chilukuri, Nymisha , Cho, Mildred K. , Cohen, Jenny K., Craven, Catherine K. , Crusco, Salvatore, Dadabhoy, Farah Z. , Dash, Dev , DeBolt, Claire , Fayanju, Oluseyi A, Fochtmann, Laura J. , Graham, Justin V., Hanna, John , Hofford, Mackenzie , Hron, Jonathan D. , Huang, Sean S, Jackson, Brian R. , Kaplan, Bonnie , Kelly, William R. , Ko, Kyungmin, Kurapati, Nikhil , Labbad, Gabriel , Lee, Julie , Leitner, Stefano, Liao, Zachary C , Melnick, Edward R. , Muniyappa, Anoop , Murray, Sara G. , Nichols-Johnson, Victoria, Novak, Laurie L. , Ogan, William Scott , Ozeran, Larry, Pageler, Natalie M. , Pandita, Deepti , Perumbeti, Ajay, Petersen, Carolyn , Pierce, Logan , Puttagunta, Raghuveer, Ramaswamy, Priya , Rogers, Kendall, Ryan, Angela M., Sarabu, Chethan , Shaw, Kate A. , Spector, Jacob D. , Starren, Justin , Stoffel, Michelle , Swanson, Karl , Tomes, Adrian, Unertl, Kim M. , Weon, Jenny L. , Wiley, Kevin , Winkelstein, Peter , Wong, Jenson, Xie, James , Yarahuan, Julia , Yung, Nathan , Zera, Chloe , Sadasivaiah, Shobha , Boyd, Andrew D , Melnick, Edward R , Petersen, Carolyn , Arvisais‐Anhalt, Simone , Benham‐Hutchins, Marge , Brecht-Doscher, Aimee, Elkin, Peter L. , Hersh, William , Kelly, William, Koppel, Ross , Lehmann, Christoph U. , Medford, Richard J , Neinstein, Aaron Barak , Rosenbloom, S. Trent , Ryan, Angela, Saleh, Sameh Nagui , Schreiber, Richard , Sim, Ida , Sirintrapun, Sahussapont Joseph , Solomonides, Anthony , Subbian, Vignesh , Trang, Karen , Whooley, Mary A. , Williamson, Drew F. K. , Ratanawongsa, Neda

Mayo Clinic

Applied Clinical Informatics | December 19, 2022 | Volume: 14 | Issue: 01 | Pages: 164-171

10.1055/a-2000-7590 | PMID 36535703 Get It

Central versus Peripheral Postcardiotomy Veno-Arterial Extracorporeal Membrane Oxygenation: Systematic Review and Individual Patient Data Meta-Analysis
Biancari, Fausto , Kaserer, Alexander , Perrotti, Andréa , Cho, Sung‐Min , Kang, Jin Kook, Dalén, Magnus , Welp, Henryk , Jónsson, Kristján , Pérez, Francisco José Hernández, Gatti, Giuseppe , Alkhamees, Khalid , Loforte, Antonio , Rosato, Stefano , Spadaccio, Cristiano , Pettinari, Matteo , Fiore, Antonio , Mäkikallio, Timo , Sahli, Sebastian D. , L’Acqua, Camilla , AlBarak, Mohammed M, Laimoud, Mohamed , Djordjevic, Ilija , Krasivskyi, Ihor , Samalavičius, Robertas , Alonso-Fernández-Gatta, Marta , Wilhelm, Markus J. , Cho, Sung-Min , Dalén, Magnus , Welp, Henryk , Jónsson, Kristján , Gatti, Giuseppe , Loforte, Antonio , Rosato, Stefano , Pettinari, Matteo , Fiore, Antonio , Sahli, Sebastian D , L'Acqua, Camilla , Laimoud, Mohamed , Djordjevic, Ilija , Krasivskyi, Ihor , Alonso-Fernandez-Gatta, Marta , Samalavicius, Robertas , Ruggieri, Vito Giovanni , Kang, Jin Kook , Ragnarsson, Sigurður , Lechiancole, Andrea , Arafat, Amr A , Albabtain, Monirah Abdulrahman , Puodžiukaitė, Lina , Mariscalco, Giovanni

Mayo Clinic

Journal of Clinical Medicine | December 14, 2022 | Volume: 11 | Issue: 24 | Pages: 7406

10.3390/jcm11247406 | PMID 36556021 Get It

Background: It is unclear whether peripheral arterial cannulation is superior to central arterial cannulation for postcardiotomy veno-arterial extracorporeal membrane oxygenation (VA-ECMO). Methods: A systematic review was conducted using PubMed, Scopus, and Google Scholar to identify studies on postcardiotomy VA-ECMO for the present individual patient data (IPD) meta-analysis. Analysis was performed according to the intention-to-treat principle. Results: The investigators of 10 studies agreed to participate in the present IPD meta-analysis. Overall, 1269 patients were included in the analysis. Crude rates of in-hospital mortality after central versus peripheral arterial cannulation for VA-ECMO were 70.7% vs. 63.7%, respectively (adjusted OR 1.38, 95% CI 1.08–1.75). Propensity score matching yielded 538 pairs of patients with balanced baseline characteristics and operative variables. Among these matched cohorts, central arterial cannulation VA-ECMO was associated with significantly higher in-hospital mortality compared to peripheral arterial cannulation VA-ECMO (64.5% vs. 70.8%, p = 0.027). These findings were confirmed by aggregate data meta-analysis, which showed that central arterial cannulation was associated with an increased risk of in-hospital mortality compared to peripheral arterial cannulation (OR 1.35, 95% CI 1.04–1.76, I2 21%). Conclusions: Among patients requiring postcardiotomy VA-ECMO, central arterial cannulation was associated with an increased risk of in-hospital mortality compared to peripheral arterial cannulation. This increased risk is of limited magnitude, and further studies are needed to confirm the present findings and to identify the mechanisms underlying the potential beneficial effects of peripheral VA-ECMO.
Sex-Specific Multiparameter Blood Test for the Early Diagnosis of Alzheimer’s Disease
Cho, Hyung Joon , Schulz, Philip , Venkataraman, Lalitha , Caselli, Richard J. , Sierks, Michael R. , Schulz, Philip

Mayo Clinic

International Journal of Molecular Sciences | December 12, 2022 | Volume: 23 | Issue: 24 | Pages: 15670

10.3390/ijms232415670 | PMID 36555310 Get It

Blood-based biomarkers are needed for the early diagnosis of Alzheimer’s disease (AD). We analyzed longitudinal human plasma samples from AD and control cases to identify biomarkers for the early diagnosis of AD. Plasma samples were grouped based on clinical diagnosis at the time of collection: AD, mild cognitive impairment (MCI), and pre-symptomatic (preMCI). Samples were analyzed by ELISA using a panel of reagents against nine different AD-related amyloid-β (Aβ), tau, or TDP-43 variants. Receiver operating characteristic (ROC) curves of different biomarker panels for different diagnostic sample groups were determined. Analysis of all of the samples gave a sensitivity of 92% and specificity of 76% for the diagnosis of AD. Early-stage diagnosis of AD, utilizing only the preMCI and MCI samples, identified 88% of AD cases. Using sex-biased biomarker panels, early diagnosis of AD cases improved to 96%. Using the sex-biased panels, we also identified 6 of the 25 control group cases as being at high risk of AD, which is consistent with what is expected given the advanced age of the control cases. Specific AD-associated protein variants are effective blood-based biomarkers for the early diagnosis of AD. Notably, significant differences were observed in biomarker profiles for the early detection of male and female AD cases.
Oncogenic deubiquitination controls tyrosine kinase signaling and therapy response in acute lymphoblastic leukemia
Jin, Qi , Gutierrez-Diaz, Blanca T. , Zhou, Yalu, Narang, Sonali , Fijalkwoski, Igor, Borin, Cristina , Laere, Jolien Van, Payton, Monique A. , Cho, Byoung-Kyu , Han, Cuijuan , Sun, Limin , Serafin, Valentina , Yacu, George, Veltri, Giulia , Dreveny, Ingrid , Goo, Young Ah , Safgren, Stephanie L. , Tsai, Yi-Chien , Bornhäuser, Beat , Suraneni, Praveen, Gaspar‐Maia, Alexandre , Kandela, Irawati , Crispino, John D. , Ntziachristos, Panagiotis , Gutierrez Diaz, Blanca , Pieters, Tim , Narang, Sonali , Fijalkwoski, Igor , Borin, Cristina , Payton, Monique , Cho, Byoung-Kyu , Han, Cuijuan , Sun, Limin , Serafin, Valentina , Von Loocke, Wouter , Veltri, Giulia , Dreveny, Ingrid , Ben-Sahra, Issam , Safgren, Stephanie L , Bornhauser, Beat , Gaspar-Maia, Alexandre , Van Vlierberghe, Pieter , Tsirigos, Aristotelis , Ntziachristos, Panagiotis , Crispino, John D , Jin, Qi , Basso, Giuseppe , Vlierberghe, Pieter Van , Tsirigos, Aristotelis

Mayo Clinic

Science Advances | December 9, 2022 | Volume: 8 | Issue: 49 | Pages: No page available

10.1126/sciadv.abq8437 | PMID 36490346 Get It

Dysregulation of kinase signaling pathways favors tumor cell survival and therapy resistance in cancer. Here, we reveal a posttranslational regulation of kinase signaling and nuclear receptor activity via deubiquitination in T cell acute lymphoblastic leukemia (T-ALL). We observed that the ubiquitin-specific protease 11 (USP11) is highly expressed and associates with poor prognosis in T-ALL. USP11 ablation inhibits leukemia progression in vivo, sparing normal hematopoiesis. USP11 forms a complex with USP7 to deubiquitinate the oncogenic lymphocyte cell–specific protein-tyrosine kinase (LCK) and enhance its activity. Impairment of LCK activity leads to increased glucocorticoid receptor (GR) expression and glucocorticoids sensitivity. Genetic knockout of USP7 improved the antileukemic efficacy of glucocorticoids in vivo. The transcriptional activation of GR target genes is orchestrated by the deubiquitinase activity and mediated via an increase in enhancer-promoter interaction intensity. Our data unveil how dysregulated deubiquitination controls leukemia survival and drug resistance, suggesting previously unidentified therapeutic combinations toward targeting leukemia.
The Mydrug Platform Trial: Efficacy and Safety of Daratumumab, Ixazomib, Pomalidomide, and Dexamethasone in Patients with Functionally High-Risk Multiple Myeloma
Kumar, Shaji , Biran, Noa , Ye, Jing Christine, Zonder, Jeffrey A. , Syed, Umar , Yesil, Jennifer, Woolley, Karen, Mulligan, George, Hofmeister, Craig C. , Kaur, Gurbakhash , Cho, Hearn Jay

Mayo Clinic

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 4434-4435

10.1182/blood-2022-163737 Get It

Odronextamab in Patients with Relapsed/Refractory (R/R) Follicular Lymphoma (FL) Grade 1-3a: Results from a Prespecified Analysis of the Pivotal Phase II Study ELM-2
Novelli, Silvana , Poon, Michelle, Champion, Rebecca A., Guidez, Stéphanie , Alonso, Aránzazu Alonso, Jagadeesh, Deepa, Cai, Jingxian, Oliveira, Carolina Leite De, Zhu, Min , Chaudhry, Aafia, Ambati, Srikanth, Kim, Tae Min , Taszner, Michał , Cho, Seok‐Goo , Gouill, Steven Le , Villasboas, José C. , Champion, Rebecca, Bachy, Emmanuel , Alonso, Aránzazu , Jagadeesh, Deepa , Merli, Michele , Tucker, David , Mohamed, Hesham , Luminari, Stefano

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 2280-2282

10.1182/blood-2022-158404 Get It

Myeloma Developing Regimens Using Genomics (MyDRUG): Longitudinal Single-Cell Transcriptional Landscape of the Myeloma and Immune Microenvironment in Relapsed/Refractory Multiple Myeloma Patients Treated with MEK-Inhibitor, Cobimetinib
Mulligan, George, Cook, April , Hamilton, Mark , Gnjatic, Sacha , Kumar, Shaji , Gnjatic, Sacha , Jayasinghe, Reyka G. , Cook, April, Kim-Schulze, Seunghee , Cho, Hearn Jay

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 7090-7091

10.1182/blood-2022-167462 Get It

A peptoid interleukin‐15 receptor antagonist suppresses inflammation and arthritis in mice
Cho, Kwang Bog , Shukla, Satya Prakash , Kannan, Maheshkumar, Amina, Sundus Jabeen, Chen, Yanping , Molligan, Jeremiah F., Mohan, Chandra , Udugamasooriya, D. Gomika , Guo, Bin , Udugamasooriya, D Gomika , Guo, Bin , Zhang, Haowen , Zhou, Shuang Ying , Chen, Yanping, Taneja, Veena

Mayo Clinic

Clinical & Translational Immunology | November 24, 2022 | Volume: 11 | Issue: 11 | Pages: No page available

10.1002/cti2.1432 | PMID 36439637 Get It

AbstractObjectiveTo discover a novel peptoid antagonist that targets the interleukin‐15 (IL‐15) receptor and to evaluate its therapeutic efficacy in the treatment of inflammation and arthritis.MethodsA new compound (IFRA3, interleukin‐15 receptor antagonist 3) was discovered using a unique on‐bead two‐colour combinatorial cell screening of a peptoid library. The interaction of IFRA3 with IL‐15 receptor was assessed by in vitro pull‐down and thermal shift assays. The efficacy of IFRA3 in treating inflammation and arthritis was evaluated in mouse models.ResultsIFRA3Q1 (a tetrameric derivative of IFRA3) inhibited the activity of IL‐15 and suppressed CTLL‐2 cell proliferation (which depends on IL‐15 activity). IFRA3Q1 exhibited strong in vivo anti‐inflammatory activity in carrageenan‐induced inflammation in mice. Furthermore, IFRA3Q1 inhibited collagen‐induced arthritis in DBA/1J mice.ConclusionBy binding to and inhibiting the function of IL‐15 receptor, IFRA3Q1 exhibited significant anti‐arthritis activity. Our findings suggest that IFRA3Q1 represents a new paradigm for arthritis therapy by targeting IL‐15 signalling.